Trailing-twelve-month (TTM) revenue is $30.85 Million with a year-over-year growth of +573.40%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $4,889,526 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-19 |
| Q4 FY2025Period ended 2025-12-31 | $16,659,524 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-04-10 |
| Q1 FY2026Period ended 2026-03-31 | $4,180,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-20 |
| Q2 FY2026Period ended 2026-06-30 | $5,123,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-14 |
| TTM revenue | $30,852,050 |
Current P/S: $368,897,109 market capitalization ÷ $30,852,050 TTM revenue = 11.96x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T13:30:00.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $5.12M.
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 7 comparable quarters.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T13:30:35.674Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|
| Collaboration Revenue | $200,000 | N/A |
| Product | $4M | $24M |
$30.85M
$30.85 Million
+573.40%
vs. $4.58M a year ago (TTM)
+0.88%
5 Year compound annual growth rate
1 Year
+573.40%
3 Year
N/A
5 Year
+0.88%
10 Year
N/A
15 Year
N/A
20 Year
N/A
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $23.85M | +$19.70M | +475.51% |
| 2024 | $4.14M | +$3.71M | +856.99% |
| 2023 | $433,026 | ($22.19M) | (98.09%) |
TTM Growth
+573.40%
3-Year CAGR
N/A
5-Year CAGR
+0.88%
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T13:30:35.674Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
